Filter posts

Docs to FDA: Biosimilars should have different names than branded drugs

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists …

The “Other Issues to Worry About” vs. GMO’s

We don’t label foods for pesticides, fertilizers or these other “conventional” food-production technologies. Only genetically …

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee …

Puerto Rico: The New Hub for Ag-Biotech Innovation

 “Biotechnology Innovation—the union of scientific discovery and capital can flourish in a supportive research and …

1 of the 2,000 Articles Supporting GMO Safety

On Thursday July 24, 2014, The Huffington Post published a blog titled Genetically-Modified Organisms (GMOs) …

21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle

How can we give patients faster access to innovative treatments and cures? That’s the question …

Digital Health in a Mobile World

Healthcare is shaping up to be an important area for all the big technology companies …

New Type of Prospective Survey Initiative

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating …

Fact vs. Fear: Are GM Enzymes in Cheese Safe?

On June 6, 2014, Scientific American released an entertaining blog entitled “Genetically Modified Cheese… is …

BIO Testifies at 21st Century Cures Hearing on PCAST

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House …